LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)
$0.04019 -0.01981 (-33.0167%)
Analysed LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) News Sources
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering
23-06-2026
yahoo.com
Ligand Announces Closing of Convertible Senior Notes Offering
25-06-2026
yahoo.com
5 Stock Setups Where Wall Street Sees the Most Upside Right Now
13-07-2026
247wallst.com
Agenus Shares Rise After Securing Up to $340 Million Financing Package (AGEN)
13-07-2026
advfn.com
3 Overlooked Stocks Positioned for the Next Market Rotation
13-07-2026
marketbeat.com
Agenus shares surge as company secures up to $340M to advance colon cancer trial
13-07-2026
proactiveinvestors.com
Agenus (AGEN) Moves 82.7% Higher: Will This Strength Last?
14-07-2026
yahoo.com
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
14-07-2026
yahoo.com
XOMA Royalty Announces Closing of Its Acquisition by Ligand
14-07-2026
yahoo.com
AGEN Stock Jumps on Securing $340M Financing to Fund Strategic Pivot
14-07-2026
yahoo.com
What is the current price of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)?
The current price of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) is $0.04019.
LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) absolute price change since previous trading day?
The absolute price change of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) since the previous trading day is $-0.01981.
LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) percentage price change since previous trading day?
The percentage price change of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) since the previous trading day is -33.0167%.
What is the most recent average sentiment score for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)?
The most recent average sentiment score for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) is 58 out of 100.
What is the most recent average sentiment for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)?
The most recent sentiment for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) is .
SEC-8K** Filing Available For LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.